Molecule Details
| InChIKey | XETSHCIFFATMOX-NHKHRBQYSA-N |
|---|---|
| Compound Name | (5S)-N-[(1S,2R)-1-benzyl-3-[cyclopropylmethyl-(4-methoxyphenyl)sulfonyl-amino]-2-hydroxy-propyl]-3-(3-fluorophenyl)-2-oxo-oxazolidine-5-carboxamide |
| Canonical SMILES | COc1ccc(S(=O)(=O)N(CC2CC2)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CN(c3cccc(F)c3)C(=O)O2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.59 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
Target Activities (2)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P03369 | gag-pol | Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) | Pathogen | PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 | 9.6 | Ki | BindingDB |
| Q72874 | pol | Human immunodeficiency virus type 1 | Pathogen | PF00077 | 9.6 | Ki | ChEMBL |